Nuveen Asset Management, LLC Regulus Therapeutics Inc. Call Options Transaction History
Nuveen Asset Management, LLC
- $340 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RGLS
# of Institutions
11Shares Held
4.71MCall Options Held
0Put Options Held
25K-
Black Rock Inc. New York, NY3.97MShares$32.4 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE401KShares$3.27 Million6.25% of portfolio
-
Jpmorgan Chase & CO New York, NY74.5KShares$608,0580.0% of portfolio
-
Peak6 Investments LLC Chicago, IL60KShares$489,6000.0% of portfolio
-
Ifp Advisors, Inc0Shares$00.0% of portfolio
About Regulus Therapeutics Inc.
- Ticker RGLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,634,400
- Market Cap $119M
- Description
- Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...